MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

Quanterix Corp

Închisă

SectorSănătate

7.39 -6.46

Rezumat

Modificarea prețului

24h

Curent

Minim

7.36

Maxim

8.13

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-5.66% downside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

106M

344M

Deschiderea anterioară

13.85

Închiderea anterioară

7.39

Sentimentul știrilor

By Acuity

25%

75%

51 / 361 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 ian. 2026, 23:29 UTC

Acțiuni populare

Stocks to Watch: Atossa Therapeutics, Union Pacific

16 ian. 2026, 22:48 UTC

Achiziții, Fuziuni, Preluări

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 ian. 2026, 22:43 UTC

Achiziții, Fuziuni, Preluări

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 ian. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

16 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Auto & Transport Roundup: Market Talk

16 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 ian. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

16 ian. 2026, 21:48 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 ian. 2026, 21:41 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 ian. 2026, 21:38 UTC

Achiziții, Fuziuni, Preluări

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 ian. 2026, 21:30 UTC

Achiziții, Fuziuni, Preluări

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 ian. 2026, 20:44 UTC

Câștiguri

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 ian. 2026, 20:42 UTC

Market Talk

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 ian. 2026, 20:28 UTC

Market Talk

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 ian. 2026, 19:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16 ian. 2026, 18:53 UTC

Market Talk

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16 ian. 2026, 18:41 UTC

Market Talk

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16 ian. 2026, 18:31 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16 ian. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16 ian. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 ian. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

16 ian. 2026, 17:03 UTC

Market Talk

Global Equities Roundup: Market Talk

16 ian. 2026, 17:03 UTC

Market Talk

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16 ian. 2026, 16:32 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16 ian. 2026, 16:20 UTC

Market Talk

Global Equities Roundup: Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

-5.66% jos

Prognoză pe 12 luni

Medie 7.5 USD  -5.66%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

51 / 361 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat